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Abstract 
Background 
Trials of new technologies to remotely monitor for signs and symptoms of worsening 
heart failure are continually emerging. The extent to which technological differences 
impact the effectiveness of non-invasive remote monitoring for heart failure 
management is unknown. 
Objective 
To examine the effect of specific technology used for non-invasive remote monitoring 
of people with heart failure on all-cause mortality and heart failure-related 
hospitalisations.  
Methods 
A sub-analysis of a large systematic review and meta-analysis was conducted. 
Studies were stratified according to the specific type of technology used and 
separate meta-analyses were performed. Four different types of non-invasive remote 
monitoring technologies were identified including structured telephone calls, 
videophone, interactive voice response devices and telemonitoring.  
Results 
Only structured telephone calls and telemonitoring were effective in reducing the risk 
of all-cause mortality (RR 0.87; 95% CI=0.75-1.01; p=0.06 and 0.62; 95% CI=0.50-
0.77; p<0.0001) and heart failure-related hospitalisations (RR 0.77; 95% CI=0.68-
0.87; p<0.001) and 0.75; 95% CI=0.63-0.91; p=0.003). More research data is 
required for videophone and interactive voice response technologies.  
Conclusions 
This sub-analysis identified that only two of the four specific technologies used for 
non-invasive remote monitoring in heart failure improved outcomes. When results of 
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studies that involved these disparate technologies were combined in previous meta-
analyses, significant improvements in outcomes were identified. As such, this study 
has highlighted implications for future meta-analyses of randomised controlled trials 
focused on evaluating the effectiveness of remote monitoring in heart failure. 
Keywords: Heart failure, remote monitoring, systematic review, meta-analysis 
  
Page 5 of 23  
Introduction 
In this era of rapidly advancing and wider community access to information 
technology, trials of new technologies to remotely monitor for signs and symptoms of 
worsening heart failure are continually emerging. Moreover, many health services 
around the world have already started to implement varying forms of these 
technologies into practice. This is most likely due to the fact that high quality meta-
analyses of randomized controlled trials have indicated that remotely monitoring 
people with heart failure reduces their relative risk of death and hospitalisations in 
comparison with usual care.1-4 However, debate regarding appropriate methods to 
compare remote monitoring studies in heart failure has emerged since the 
publication of results from two randomized controlled trials that directly contrasted 
with earlier meta-analyses.5, 6   
In this regard, it is important to note that many specific technological differences 
exist. For example, technologies vary from a structured telephone call (normal 
telephone, conducted in person, supported by computer data gathering) to 
interactive voice response systems (a computer voice guides the patient to press 
phone keys in response to questions, similar to telephone banking). The extent to 
which these technological differences impact the effectiveness of post-discharge 
heart failure management have been unknown. The aim of this study was to 
examine the effect of specific technologies on outcomes in heart failure 
management.  
Methods 
We conducted a sub-analysis of our previously published systematic review and 
meta-analysis using Cochrane methodology.3, 7, 8 First, the 25 randomized controlled 
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trials included in our systematic review were further scrutinized in order to group the 
studies according to the specific type of non-invasive remote monitoring technology 
that was used. Then, separate meta-analyses of all-cause mortality and heart failure-
related hospitalizations were performed for each group of studies. This sub-analysis 
was not published in the Cochrane Review.8 
Information sources and search strategy 
The full report of the information sources and search strategy are published 
elsewhere. In brief, though, as per the protocol,7 all known relevant search engines 
and electronic databases were utilized for the period to November 2008. In addition, 
bibliographies of relevant studies and systematic reviews were hand-searched. 
Abstracts from major cardiology conferences were also hand-searched for the years 
2006, 2007 and 2008. Keywords included heart failure, cardiac failure, telehealth, 
telephone, telemonitoring and disease management. Language restrictions were not 
applied.  
Study selection 
Randomized controlled trials of non-invasive remote monitoring for heart failure 
compared to usual care were eligible to be included in this sub-analysis if they were 
published in full in a peer-reviewed journal.7 Studies which were published as 
abstracts were excluded because in the main review, it was identified that addition of 
the studies published as abstracts had no substantial impact on results of the meta-
analyses.3  
Data extraction 
Two reviewers independently reviewed the results of each search according to the 
inclusion and exclusion criteria with a standardised data extraction tool and also 
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applied standard scales to judge study quality and risk of bias. A third reviewer 
adjudicated. 
Data analysis 
Meta-analyses on the primary outcomes of all-cause mortality, CHF-related, and all-
cause hospitalizations were performed according to Mantel–Haenzel methods, using 
a fixed effects model, risk ratios (RR), intention-to-treat, and assessment of statistical 
heterogeneity using the I2 statistic.7 All analyses were performed using Review 
Manager (RevMan) Version 5.0 (Copenhagen: The Nordic Cochrane Centre, 
Cochrane Collaboration, 2008).7 In technology applications where there were only a 
small number of studies, results were not subjected to meta-analysis and instead 
individual results have been presented and discussed narratively. 
Results 
Technologies identified 
Four different modes of non-invasive remote monitoring technologies were identified 
among the 25 randomised controlled trials included in our systematic review Table 1. 
A summary of the studies included in our review is reported in detail elsewhere.8 The 
specific technologies identified include: 1) structured telephone calls; 2) videophone; 
3) interactive voice response, which involved the manual input of data using a 
telephone keypad in response to questions from a computerized interactive voice 
response system; and 4) telemonitoring, which involved transmission of physiological 
data, such as weight, heart rate and rhythm, oxygen saturations and blood pressure, 
from the measuring device to a central server via telephonic, satellite or broadband 
capabilities for interpretation by the healthcare team. Table 2 presents a summary of 
the results of meta-analyses, or results of single randomised controlled trials where 
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meta-analysis could not be conducted, according to the type of technology used. 
Structured telephone call 
Meta-analysis of 15 studies that compared structured telephone calls for post-
discharge heart failure management with usual care identified reductions in all-cause 
mortality (RR 0.87; 95% CI=0.75-1.01; p=0.06) Figure 1. Similarly, the relative risk of 
heart failure-related hospitalisations was reduced in meta-analysis of 13 studies that 
involved structured telephone calls (RR 0.77; 95% CI=0.68-0.87; p<0.0001) Figure 2. 
Videophone 
Only one study (n=148 participants) examined the effectiveness of videophone 
follow-up on heart failure outcomes.23 No differences were found for all-cause 
mortality and in this study (RR 1.28; 95% CI=0.66-2.52). Hospitalisations were not 
reported.  
Interactive Voice Response 
The effectiveness of interactive voice response devices was examined in two studies 
included in our review.17, 33 No significant reductions in the relative risk of all-cause 
mortality, all-cause hospitalisations or heart failure-related hospitalisations were 
observed in either of these studies (Table 2). 
Telemonitoring 
Significant reduction in the relative risk of all-cause mortality (RR 0.62; 95% CI=0.5-
0.77; p<0.0001) was identified in meta-analyses of nine studies Figure 3. Fewer 
studies reported on heart-failure related hospitalisations. However, the relative risk of 
heart failure-related hospitalisations (RR 0.75; 95% CI=0.63-0.91; p=0.003) was also 
reduced compared with usual care in meta-analysis of three studies Figure 4. 
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Interactive Voice Response and telemonitoring 
One arm of the study reported by Mortara et al.17 included a group of patients who 
used both interactive voice response and telemonitoring technologies. No significant 
differences were identified for all-cause mortality, all-cause hospitalizations or heart 
failure-related hospitalisations between the intervention and control groups in this 
study. 17  
Risk of bias 
The heterogeneity within the structured telephone call and telemonitoring studies 
that were subjected to meta-analysis was low for all-cause mortality (I² = 0%). Meta-
analyses of all-cause and heart failure-related hospitalizations for structured 
telephone call studies was low (I² = 13% and 7% respectively). In contrast, for 
telemonitoring studies, heterogeneity for all-cause hospitalizations was substantial (I² 
= 81%) and for heart failure-related hospitalizations, heterogeneity was moderate 
(I242%) (I² statistic Low = 0-40%; Moderate = 30-60%; Substantial = 50-90%, 
Considerable 75-100%).34 
Discussion 
This sub-analysis of our Cochrane Collaboration systematic review has identified 
that only two of the four specific technologies used for non-invasive remote 
monitoring in heart failure showed statistically significant improvements on the 
primary outcomes. These results are in contrast to our previous systematic review 
and those published by other groups, where these disparate technologies have been 
combined to show significant improvements in outcomes.2, 3 As such, the results 
from this sub-analysis have considerable implications for future research and provide 
methodological insights to consider in the conduct of future meta-analyses of 
Page 10 of 23  
randomised controlled trials focused on evaluating the effectiveness of remote 
monitoring in heart failure. 
Interestingly, one of the technologies that significantly improved outcomes in this 
sub-analysis was the telephone call between a patient and health professional 
following a structured format. The other effective technology was telemonitoring. The 
most notable difference between these two effective technologies is that, in the 
studies that involved a structured telephone call, education, self–care and symptom 
monitoring were an essential part of the process conducted. In contrast, the studies 
that involved telemonitoring only involved transmission of physiological data and 
maintained dependence on the providers. The unique contribution of incorporating 
the provision of education for self-care and self-monitoring empowerment and 
autonomy has not specifically been determined. However, results from our sub-
analysis suggest the additional benefit may be limited, as both strategies produced 
significant reductions in mortality and hospitalisations in our meta-analyses. As such, 
further investigation is required, as there are cost and health service implications 
associated with the allocation of a case manager to conduct follow up calls to 
patients with heart failure. For example, it has been reported that it is typical for a 
case manager to provide follow-up calls  for fifty patients in comparison to the two to 
three hundred-patient capacity of an telemonitoring strategy.35 On the other hand, 
more complex information technology infrastructure is required to facilitate 
telemonitoring as opposed to a simple telephone call, which might limit the extent to 
which telemonitoring can be made available for heart failure patients to access. 
However, only 50% of the trials that involved structured telephone calls were 
conducted after 2005 in comparison to 80% that involved telemonitoring. This 
temporal trend, which indicates a recent preference for evaluating the potentially 
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more cost-effective technology of telemonitoring for remote monitoring in heart 
failure, may indicate that information technology infrastructure issues are not a 
significant barrier to implementation.  
We have also considered the results of our sub-analysis in regard to the 
mechanisms by which providing follow up for heart failure patients with either a 
structured telephone call or with telemonitoring might produce their protective 
effects. In this regard, recent evidence suggests that remote monitoring, in which 
change in weight is the only variable recorded, is not sensitive enough to detect 
worsening heart failure. Zhang and colleagues found only 20% of episodes of 
worsening heart failure were preceded by an increase in weight.36 It has been 
proposed that fluid redistribution as opposed to fluid accumulation is an important 
contributory mechanism in exacerbation of heart failure.37, 38 Three studies of 
telemonitoring included in our sub-analysis monitored weight in isolation, whereas 
others included blood pressure, electrocardiography and oxygen saturations 
measurement. As such, consideration should be given to measuring more than 
weight in telemonitoring interventions. Moreover, while the provision of education 
during remote follow-up would theoretically lead to improved self-care in patients 
with heart failure, a recent review that focused specifically on this issue noted that 
results from trials are equivocal.39 For these reasons, we suggest that future trials 
should directly compare structured telephone call and telemonitoring strategies to 
provide further insight into which particular technology is the most effective in terms 
of clinical and cost-effectiveness.  
In contrast to structured telephone calls and telemonitoring, we have identified in this 
sub-analysis that more research data would be required to provide a robust 
evaluation of the effectiveness of two other specific technologies; videophone and 
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interactive voice response systems. That being said, the need to conduct further 
investigations of videophone technology is not abundantly clear from the evidence at 
hand, because the use of structured telephone calls seems to be a highly effective 
remote monitoring strategy. Videophone technology is associated with more costs 
than telephone follow-up, due to the cost of equipment.23 As such, if investigations of 
videophone technology are conducted in the future, it is suggested that the research 
design should incorporate a group of patients receiving structured telephone call 
follow-up for comparison.  
Interactive voice response technology was investigated in only two studies included 
in our review.17, 33 The trials enrolled 594 patients in total and there were no 
significant reductions in mortality or hospitalisations identified in either of the studies. 
These findings are consistent with a more recent and larger randomised controlled 
trial of interactive voice response technology, which was published after our 
systematic review. The Tele-HF trial, which randomised 1,653 patients, found that 
there were no significant differences between the primary outcome of hospitalisation 
or death within six months.5 Of note, though, when we grouped the two interactive 
voice response studies under the broader ‘telemonitoring’ group in our Cochrane 
review, reductions in mortality and hospitalisations remained statistically significant. 
Therefore, based on the disparate results of our sub-analysis, it does not seem that 
grouping interactive voice response systems with telemonitoring technologies is an 
appropriate strategy for comparison of clinical studies of remote monitoring for heart 
failure. For this reason, in the update of our Cochrane Review, capturing the latest 
randomized controlled trial evidence, subgroup analysis of specific technologies will 
provide further insight into the effectiveness of interactive voice response technology 
in improving post-discharge heart failure follow-up care. Once these findings of the 
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updated review are published, if it is confirmed that remote monitoring using an 
interactive voice response device is not associated with reductions in mortality or 
hospitalisations, serious consideration should be given as to the appropriateness of 
further investigations of this particular technology.  
It should also be noted that, to provide more standardized comparisons between 
trials of remote monitoring for heart failure, Anker and colleagues recently proposed 
a classification scheme in their review of contemporary issues related to remote 
telemedical management of heart failure.35 Their proposed scheme comprised four 
generations. The main discriminating factors between generations are the methods 
by which the information that is collected is used by the health care practitioner and 
whether or not data from invasive devices have been incorporated into clinical 
decision-making. Whilst we share Anker and colleagues view that it is important to 
establish robust methods of comparing the results of similar studies in order to 
determine which specific approach is the most effective, as we have identified in this 
sub-analysis,  there are substantial differences in outcomes between just the non-
invasive technologies, therefore it does not seem appropriate to apply this specific 
classification scheme as the sole basis to make comparisons.35 
Limitations 
It is important to note that the degree of heterogeneity in this sub-analysis was 
similar to that reported in our overall Cochrane review. This is likely due to the fact 
that only one study that involved videophone technology was separated out from the 
broader structured telephone support category and only two studies that involved 
interactive voice response technology were separated out from the broader 
telemonitoring category. An important limitation of this analysis is the exclusion of 
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more recent randomized controlled trials of non-invasive remote monitoring in heart 
failure. In order to avoid introducing bias into our methodology, we have limited this 
analysis to the studies currently included in our Cochrane review. The latest 
randomized controlled trial evidence will be included in the update of our Cochrane 
Review. 
Conclusion 
This sub-analysis has identified that while four unique technologies for the non-
invasive remote monitoring of heart failure have been evaluated in randomised 
controlled trials, only structured telephone calls and telemonitoring, in which 
physiological data is automatically transmitted, reduced the relative risk of all-cause 
mortality and hospitalizations when results were combined in the meta-analyses. 
More research data is required to evaluate the effectiveness of videophone and 
interactive voice response technologies.   
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Table 1 Study characteristics categorized by type of technology 
Study Intervention Follow-up 
Structured Telephone Call vs. Usual Care 
Barth (2001)9 Education and monitoring. 3 months 
Cleland et al. (2005)10  
TEN-HMS Study 
Education and monitoring. 240 days; 
15 months 
DeBusk et al. (2004)11 CHF lifestyle education and 
medication management.  
12 months 
DeWalt et al. (2006)12 Education and monitoring. 12 months 
Galbreath et al. (2004)13 Education and monitoring. 18 months 
Gattis et al. (1999)14   
PHARM Study 
Pharmacist-led medication review 
and education.  
6 months 
GESICA Investigators  
(2005)15 DIAL Trial  
Education and monitoring. 16 months 
(mean) 
Laramee et al. (2003)16 Education and monitoring. 3 months 
Mortara et al. (2009)17 
HHH Study 
Education and monitoring. 
 
11·6 months 
(mean) 
Rainville (1999)18 Pharmacist-led medication 
review, education, medication 
management.  
12 months 
Ramachandran et al. (2007) Education and drug dose 
modification 
6 months 
Riegel et al. (2002)19 Education and counseling.  6 months 
Riegel et al. (2006)20 Education, monitoring and 6 months 
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guidance.  
Sisk et al. (2006)21 Patient assessment and 
education.  
12 months 
Tsuyuki et al. (2004)22 Education and monitoring.  6 months 
Wakefield et al. (2008)23 Education and monitoring. 12 months 
Videophone vs. Usual Care 
Wakefield et al. (2008)23 Education and monitoring. 12 months 
Interactive Voice Response vs. Usual Care 
Capomolla et al. (2004)24 Weight, systolic BP, HR.  12 months 
Mortara et al. (2009)17 
HHH Study 
Weight, HR, BP and symptoms 
(Telemonitoring data was 
collected but not used)  
11·6 months 
(mean) 
Interactive Voice Response plus Telemonitoring vs. Usual Care 
Mortara et al. (2009)17 
HHH Study 
Weight, HR, BP and symptoms 
plus ECG, respiration rate and 
physical activity 
11·6 months 
(mean) 
Telemonitoring vs. Usual Care 
Antonicelli et al.  
(2008)25 
BP, HR, weight and 24h urine 
output, ECG. 
12 months 
Balk et al. (2008)26 MOTIVA system.   288 days 
(mean) 
Cleland et al. (2005)10  
TEN-HMS Study  
Weight, BP, ECG.  240 days; 
15 months 
de Lusignan et al.  Pulse, BP, weight.  12 months 
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(2001)27 
Giordano et al. (2008)28 One-lead ECG.  12 months 
Goldberg et al. (2003)29 
WHARF Trial 
Weight.  6 months 
(mean) 
Kielblock et al. (2007)30 Weight.  12 months 
Mortara et al. (2009)17 
HHH Study 
Weight, BP and symptoms.  11·6 months 
(mean) 
Soran et al. (2008)31 Weight.  6 months 
Woodend et al. (2003)32 Weight, ECG, BP.  3 and 12 
months   
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Table 2 Outcomes according to type of technology used 
Technology All-cause mortality Heart failure-related 
hospitalizations 
Structured telephone 
call vs usual Care 
Meta-analysis of 15 
studies: 
RR 0.87  
(95% CI=0.75-1.01) 
Meta-analysis of 13 
studies: 
RR 0.77  
(95% CI=0.68-0.87) 
Video-phone vs usual 
care 
Wakefield et al.23 
RR 1.28 
(95% CI=0.66-2.52) 
Not reported 
Interactive voice 
response vs usual care 
Capomolla et al.33  
RR 0.7  
(95% CI= 0.24-2.11) 
Mortara et al.17 
RR 1.32  
(95% CI=0.51-3.44) 
Mortara et al.17 
RR 1.03  
(95% CI=0.60 -1.78) 
Telemonitoring and  
Interactive voice 
response vs usual care  
Mortara et al.17 
RR 1.41  
(95% CI=0.56-3.53) 
Mortara et al.17 
RR 1.02  
(95% CI=0.60 – 1.74) 
Telemonitoring vs 
usual care 
Meta-analysis of 9 
studies: 
RR 0.62  
(95% CI=0.50-0.77) 
Meta-analysis of 3 
studies: 
RR 0.75  
(95% CI=0.63-0.91) 
Figure 1 Effect of structured telephone calls on all-cause mortality
Figure 2 Effect of structured telephone calls on heart-failure related hospitalisations
Figure 3 Effect of telemonitoring on all-cause mortality
Figure 4 Effect of telemonitoring on heart failure-related hospitalisations
